Mitochondrial and metabolic alterations in cancer cells |
| |
Affiliation: | 1. Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy;2. Department of Innovative Technologies in Medicine and Dentistry, University “G. d’Annunzio”, Chieti, Italy |
| |
Abstract: | Metabolic alterations have been observed in many cancer types. The deregulated metabolism has thus become an emerging hallmark of the disease, where the metabolism is frequently rewired to aerobic glycolysis. This has led to the concept of “metabolic reprogramming”, which has therefore been extensively studied. Over the years, it has been characterized the enhancement of aerobic glycolysis, where key mutations in some of the enzymes of the TCA cycle, and the increased glucose uptake, are used by cancer cells to achieve a “metabolic phenotype” useful to gain a proliferation advantage. Many studies have highlighted in detail the signaling pathways and the molecular mechanisms responsible for the glycolytic switch. However, glycolysis is not the only metabolic process that cancer cells rely on. Oxidative Phosphorylation (OXPHOS), gluconeogenesis or the beta-oxidation of fatty acids (FAO) may be involved in the development and progression of several tumors. In some cases, these metabolisms are even more crucial than aerobic glycolysis for the tumor survival. This review will focus on the contribution of these alterations of metabolism to the development and survival of cancers. We will also analyze the molecular mechanisms by which the balance between these metabolic processes may be regulated, as well as some of the therapeutical approaches that can derive from their study. |
| |
Keywords: | Metabolism Cancer Mitochondria Fatty acids Amino acids OXPHOS |
本文献已被 ScienceDirect 等数据库收录! |
|